Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−488,098−100.0%Sold outHolders
Q1 2026488,098$7.06M<0.1%−1,060,905−68.5%ReducedHolders
Q4 20251,549,003$22.1M<0.1%−2,319,207−60.0%ReducedHolders
Q3 20253,868,210$30.5M<0.1%−2,494,040−39.2%ReducedHolders
Q2 20256,362,250$36.5M<0.1%+4,071,968+177.8%AddedHolders
Q1 20252,290,282$18.7M<0.1%+729,872+46.8%AddedHolders
Q4 20241,560,410$14.7M<0.1%+889,968+132.7%AddedHolders
Q3 2024670,442$7.16M<0.1%+581,167+651.0%AddedHolders
Q2 202489,275$885.6K<0.1%−35,751−28.6%ReducedHolders
Q1 2024125,026$1.47M<0.1%−161,198−56.3%ReducedHolders
Q4 2023286,224$4.06M<0.1%−73,967−20.5%ReducedHolders
Q3 2023360,191$4.38M<0.1%−771,735−68.2%ReducedHolders
Q2 20231,131,926$14.2M<0.1%−519,671−31.5%ReducedHolders
Q1 20231,651,597$18.3M<0.1%−581,728−26.0%ReducedHolders
Q4 20222,233,325$27.3M<0.1%−670,171−23.1%ReducedHolders
Q3 20222,903,496$30.3M0.1%−65,240−2.2%ReducedHolders
Q2 20222,968,736$31.9M0.1%−75,702−2.5%ReducedHolders
Q1 20223,044,438$28.8M<0.1%+279,142+10.1%AddedHolders
Q4 20212,765,296$31.9M<0.1%+573,279+26.2%AddedHolders
Q3 20212,192,017$20.9M<0.1%−766,130−25.9%ReducedHolders
Q2 20212,958,147$28.5M<0.1%−1,456,829−33.0%ReducedHolders
Q1 20214,414,976$43.6M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.